Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial

Journal:
Nature Medicine
Published:
Affiliations:
44
Authors:
76
Institutions Authors Share
Peter MacCallum Cancer Centre (Peter Mac), Australia
12.750000
12.750000
0.17
The University of Melbourne (UniMelb), Australia
12.250000
12.250000
0.16
The University of Sydney (USYD), Australia
5.500000
0.07
Royal North Shore Hospital (RNSH), Australia
5.000000
0.07
Vancouver Prostate Centre (VPC), Canada
4.833333
0.06
Royal Brisbane and Women's Hospital (RBWH), Australia
4.000000
0.05
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Australia
3.000000
0.04
Sir Charles Gairdner Hospital (SCGH), Australia
2.500000
0.03
Fiona Stanley Hospital (FSH), Australia
2.500000
0.03
Liverpool Hospital, Australia
2.000000
0.03
Royal Adelaide Hospital (RAH), Australia
2.000000
0.03
Monash Health, Australia
2.000000
0.03
University of New South Wales (UNSW Sydney), Australia
1.500000
0.02
Monash University, Australia
1.166667
0.02
Garvan Institute of Medical Research, Australia
1.000000
0.01
The University of Western Australia (UWA), Australia
1.000000
0.01
The University of Queensland (UQ), Australia
1.000000
0.01
Calvary Mater Newcastle, Australia
1.000000
0.01
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.01
Health New Zealand Auckland, New Zealand
1.000000
0.01
Hunter New England Local Health District, Australia
1.000000
0.01
Olivia Newton-John Cancer Wellness and Research Centre, Australia
1.000000
0.01
Macquarie University Hospital, Australia
1.000000
0.01
St Vincent's Hospital Sydney, Australia
0.833333
0.01
The Kinghorn Cancer Centre (TKCC), Australia
0.666667
0.01
Austin Health, Australia
0.500000
0.01
La Trobe School of Cancer Medicine, Australia
0.500000
0.01
Olivia Newton-John Cancer Research Institute (ONJCRI), Australia
0.500000
0.01
Chris O'Brien Lifehouse, Australia
0.500000
0.01
Tampere University, Finland
0.500000
0.01
Tays Cancer Centre, Finland
0.500000
0.01
Eastern Health, Australia
0.500000
0.01
BC Cancer Agency (BCCA), PHSA, Canada
0.500000
0.01
University of Washington (UW), United States of America (USA)
0.250000
0.00
Fred Hutchinson Cancer Center, United States of America (USA)
0.250000
0.00